The Innovative Medicines Initiative Consortium RESOLUTE has started to develop tools and produce data sets to de-orphanize transporters in the solute carrier protein (SLC) superfamily, thereby lowering the barrier for the scientific community to explore SLCs as an attractive drug target class.
???? Great news! Our first article highlighting @RESOLUTE_IMI mission is now published in @NatRevDrugDisc‼️ This represents an important milestone to create awareness on #SLC #transporters research! Check it out: https://t.co/TN2MEe1POk. Please spread the word! #openscience. pic.twitter.com/pvnXW834n2
— RESOLUTE (@RESOLUTE_IMI) April 7, 2020 on Twitter
Of course, we would particularly like to congratulate our 9 #pharminfo co-authors:
- Giulia Banci
- Claire Colas
- Daniela Digles
- Gerhard Ecker
- Barbara Füzi
- Viktoria Gamsjäger
- Melanie Grandits
- Riccardo Martini
- Florentina Troger
doi: 10.1038/d41573-020-00056-6
Acknowledgements
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777372. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
